Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 15/20 | 0.41 |
| ▸ | CA2 | P00918 | 15/20 | 0.41 |
| ▸ | CA9 | Q16790 | 10/20 | 0.38 |
| ▸ | CA12 | O43570 | 7/20 | 0.38 |
| ▸ | CA4 | P22748 | 2/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6749325 | 0.86 | CA1 (0.35) | CA1CA2CA9CA12CA4 | |
| SCHEMBL6749341 | 0.82 | HDAC6 (0.39) | HDAC6 | |
| SCHEMBL6747458 | 0.80 | HDAC6 (0.40) | HDAC6MEN1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL6747294 | 0.79 | HDAC6 (0.39) | HDAC6 | |
| SCHEMBL6745468 | 0.79 | HDAC6 (0.43) | HDAC6KMT2A | |
| SCHEMBL6745492 | 0.79 | HDAC6 (0.40) | HDAC6 | |
| SCHEMBL7145315 | 0.78 | HDAC6 (0.39) | HDAC6 | |
| SCHEMBL6747276 | 0.77 | HDAC6 (0.42) | CA2HDAC6 | |
| SCHEMBL6749072 | 0.77 | HDAC6 (0.38) | HDAC6 | |
| SCHEMBL6749091 | 0.77 | HDAC6 (0.43) | HDAC6SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040092737-A1 | Benzopiperidine derivatives | EISAI CO., LTD. | 2004-05-13 | — | — | US | disclosed |
| EP-0934941-A1 | BENZOPIPERIDINE DERIVATIVES | Eisai Co., Ltd. (JP) | 1999-08-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040092737-A1 | Benzopiperidine derivatives | HLA-DRB1, HRH1, HRH2 | CA1 2991/4885CA2 2670/4885CA9 3041/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.